Tag: NYSE:TAK

Analysts Viewpoint

BofA Securities upgrades Takeda Pharmaceutical Co ADR (TAK) rating to a Buy

Takeda Pharmaceutical Co ADR’s recently made public that its President, Plasma-Derived Ther Giles Richard Platford acquired Company’s shares for reported

Stock Earnings

Checking in on Takeda Pharmaceutical Co ADR (TAK) after recent insiders movement

Takeda Pharmaceutical Co ADR’s filing revealed that its President, Plasma-Derived Ther Giles Richard Platford acquired Company’s shares for reported $0.28

Analysts Viewpoint

Taking a look at what insiders are doing to gauge the Takeda Pharmaceutical Co ADR (TAK)’s direction

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its